- Placenta percreta with a vaginal fistula after successful management by uterine transverse fundal incision and subsequent cesarean hysterectomy
-
Matsuzaki , Matsuzaki , Ueda Y, Egawa-Takata T, Mimura K, Kanagawa T, Morii E, Kimura T
- KMID: 2051722
- Obstet Gynecol Sci.
- 2014 Sep;57(5):397-400.
- doi: 10.5468/ogs.2014.57.5.397
Placenta previa presents a highest risk to pregnancy, and placenta accreta is the most serious. Placenta accreta requires cesarean delivery and often results in massive obstetric hemorrhage and higher maternal... -
- CITED
-
- Close
- SHARE
-
- Close
- Changes in urinary potassium excretion in patients with chronic kidney disease
-
Ueda Y, Ookawara S, Ito K, Miyazawa H, Kaku Y, Hoshino T, Tabei K, Morishita
- KMID: 2311826
- Kidney Res Clin Pract.
- 2016 Jun;35(2):78-83.
- doi: 10.1016/j.krcp.2016.02.001
BACKGROUND: Hyperkalemia is one of the more serious complications of chronic kidney disease (CKD), and the cause of potassium retention is a reduction in urinary potassium excretion. However, few studies... -
- CITED
-
- Close
- SHARE
-
- Close
- Relationship between serum total carbon dioxide concentration and bicarbonate concentration in patients undergoing hemodialysis
-
Hirai K, Ookawara S, Morino J, Minato S, Kaneko S, Yanai K, Ishii H, Matsuyama M, Kitano T, Shindo M, Miyazawa H, Ito K, Ueda Y, Watano T, Fujino S, Omoto K, Morishita Y
- KMID: 2509805
- Kidney Res Clin Pract.
- 2020 Dec;39(4):441-450.
- doi: 10.23876/j.krcp.19.126
Background: Few studies have investigated the relationship between serum total carbon dioxide (CO2) concentration and bicarbonate ion (HCO3-) concentration in patients undergoing hemodialysis. We determined the agreement and discrepancy between... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical utility of CA-125 in the management of uterine carcinosarcoma
-
Matsuo K, Ross MS, Yunokawa M, Johnson MS, Machida H, Omatsu K, Klobocista MM, Im DD, Satoh S, Baba T, Ikeda Y, Bush SH, Hasegawa K, Blake EA, Takekuma M, Shida M, Nishimura , Adachi S, Pejovic T, Takeuchi S, Yokoyama T, Ueda Y, Iwasaki K, Miyake TM, Yanai S, Nagano T, Takano T, Shahzad MM, Ueland FR, Kelley JL, Roman LD
- KMID: 2431233
- J Gynecol Oncol.
- 2018 Nov;29(6):e88.
- doi: 10.3802/jgo.2018.29.e88
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial
-
Hirai K, Ookawara S, Kitano T, Miyazawa H, Ito K, Ueda Y, Kaku Y, Hoshino T, Mori H, Yoshida I, Kubota K, Yamaji Y, Takeda T, Nakamura Y, Tabei K, Morishita
- KMID: 2384618
- Kidney Res Clin Pract.
- 2017 Jun;36(2):159-166.
- doi: 10.23876/j.krcp.2017.36.2.159
BACKGROUND: Mizoribine (MZR) is an immunosuppressive drug used in Japan for treating patients with lupus nephritis and nephrotic syndrome and has been also reportedly effective in patients with immunoglobulin A... -
- CITED
-
- Close
- SHARE
-
- Close
- Approximation of bicarbonate concentration using serum total carbon dioxide concentration in patients with non-dialysis chronic kidney disease
-
Hirai K, Minato S, Kaneko S, Yanai K, Ishii H, Kitano T, Shindo M, Miyazawa H, Ito K, Ueda Y, Kaku Y, Hoshino T, Watano T, Fujino S, Ookawara S, Omoto K, Morishita
- KMID: 2457724
- Kidney Res Clin Pract.
- 2019 Sep;38(3):326-335.
- doi: 10.23876/j.krcp.19.027
BACKGROUND: We investigated the relationship between serum total carbon dioxide (COâ‚‚) and bicarbonate ion (HCO₃â») concentrations in pre-dialysis chronic kidney disease (CKD) patients and devised a formula for predicting low... -
- CITED
-
- Close
- SHARE
-
- Close
